L&C BIO (290650) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, L&C BIO (290650) reported revenue of 85.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202585.5 billion KRW4.4 billion KRW-138.2 billion KRW[source]
202472.1 billion KRW2.5 billion KRW141.0 billion KRW[source]
202368.9 billion KRW7.7 billion KRW48.5 billion KRW[source]
202252.6 billion KRW9.5 billion KRW5.7 billion KRW[source]
202145.7 billion KRW13.2 billion KRW15.6 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025333.4 billion KRW220.0 billion KRW113.3 billion KRW[source]
2024283.2 billion KRW157.3 billion KRW125.8 billion KRW[source]
2023223.8 billion KRW88.6 billion KRW135.2 billion KRW[source]
2022159.2 billion KRW71.3 billion KRW87.9 billion KRW[source]
202184.1 billion KRW6.3 billion KRW77.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice